EUVIMEDEUVIMED entdecken
Crossref

Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study

Sacha Kuil iD, Roisin Bavalia, Anders Boyd, Menno de Jong, Laura van Buul, Constance Schultsz

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkaf451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Sacha Kuil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Nursing Homes, Anti-Bacterial Agents, Urinary Tract Infections, Drug Resistance, Bacterial. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Public Health Service of Amsterdam, Antibiotic Resistance Healthcare Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the feasibility of lot quality assurance sampling (LQAS) for defining high prevalence of antibiotic-resistant (ABR) uropathogens in Dutch nursing homes.

Methods

In this cross-sectional study, we constructed ‘lots’ of residents with urinary tract infections (UTIs) across three Dutch nursing home organizations (21 locations, 2095 beds) between February and July 2023. Resistance thresholds for common antibiotics used in empirical antibiotic therapy (EAT) were set at 20% (upper) and 5% (lower). Per organization ≥44 strains of E. coli/Klebsiella spp. were consecutively sampled; ≥ 5 resistant strains indicated ‘high’ ABR prevalence. Aggregate data were used in an adapted, meta-regression model to identify structural ABR determinants. Three multidisciplinary focus groups were conducted to identify implementation requirements for LQAS-based ABR surveillance.

Results

From 298 urine specimens 132 E. coli/Klebsiella strains were identified. Across all three organizations, amoxicillin-clavulanic acid (first-choice EAT for pyelonephritis) was classified as ‘high’, while seven other antibiotics, including three EAT agents, had varying classifications. Higher ABR was associated with higher proportions of rehabilitation/short-stay care beds, higher number of shared bathrooms, higher hospital admission rates and higher antibiotic usage. Focus groups revealed that defining a ABR upper threshold for LQAS was difficult, that multiple factors influenced the choice of EAT (e.g. side effects), and that the role of ABR prevalence in EAT-related decision making was unclear.

Conclusions

Using LQAS to classify E. coli/Klebsiella ABR in nursing homes was feasible within 4 months. To effectively inform local EAT, consensus is needed on the threshold of maximum acceptable level of ABR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nursing HomesAnti-Bacterial AgentsUrinary Tract InfectionsDrug Resistance, BacterialQuality Assurance, Health CareHumansCross-Sectional StudiesNetherlandsFeasibility StudiesEscherichia coliMaleAgedFemalePrevalenceAged, 80 and overEscherichia coli InfectionsKlebsiella InfectionsMicrobial Sensitivity Tests

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
  • Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Institute for Immunity & Infectious Diseases (AI&I), Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Stichting HIV Monitoring, Amsterdam, the Netherlands.
  • Department of Medicine for Older People, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

ORCID-Profile: Sacha Kuil

Förderung

  • Public Health Service of Amsterdam
  • Antibiotic Resistance Healthcare Network

Zitieren

APA

Kuil, S., Bavalia, R., Boyd, A., de Jong, M., van Buul, L., & Schultsz, C. (2026). Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf451

Vancouver

Kuil S, Bavalia R, Boyd A, de Jong M, van Buul L, Schultsz C. Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkaf451

BibTeX
@article{Kuil2026,
  author = {Kuil, Sacha and Bavalia, Roisin and Boyd, Anders and de Jong, Menno and van Buul, Laura and Schultsz, Constance},
  title = {Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkaf451}
}
Kostenlos starten →